More than 97% of Pronova’s shareholders accept BASF’s offer for Pronova BioPharma
The extended offer period for BASF’s [Frankfurt: BAS, LSE: BFA, SWX: AN] voluntary cash offer to shareholders of Pronova BioPharma ASA, Lysaker, Norway, [OBX: PRON], ended on January 18, 2013, 16:30 CET. During the offer period, a total of 293,975,655 Pronova shares have been tendered to BASF. This corresponds to 97.7% of all Pronova shares.

You will find the long version of the press release in the internet under the following link:
For further information please contact:  Mr Thomas Nonnast
Tel:  +49 30 206 2950-34
Fax:  +49 30 206-2950-20
Click here to Visit Website:
DISCLAIMER: News items are included on the website in good faith. The accuracy of claims or statements made in this news item have not been independently verified by and no responsibility is accepted by for the accuracy of the contents of this news item. Readers are advised that they should carry out additional checks on the accuracy of this news item, and they should also check that any products offered for sale are of a suitable quality and that their use satisfies all legal requirements.